-
News
OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease…
Read More » -
News
NASDAQ-Listed JE Cleantech Announces Strong FY2022 Results on the back of Post-Opening Economic Rebound
[ad_1] – JE Cleantech Holdings Ltd (NASDAQ: JCSE) released its annual report for the financial year ended December 31, 2022,…
Read More » -
Aristocrat Group (OTC: ASCC) to Begin Preliminary Negotiations of the Acquisition of Merica Bourbon
[ad_1] HOUSTON, TX- (NewMediaWire) – May 1, 2023 – We are proud to announce that Aristocrat Group (OTC: ASCC) have…
Read More » -
Forian Inc. to Announce First Quarter 2023 Results on May 12, 2023
[ad_1] Newtown, PA – (NewMediaWire) – May 01, 2023 – Forian Inc. (Nasdaq:FORA), a provider of data science driven information…
Read More » -
Cognitive impairment after stroke is common, and early diagnosis and treatment needed
[ad_1] Statement Highlights: More than half of people who survive a stroke develop cognitive impairment within the first year after…
Read More »